RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024
All resolutions presented by the Company have been adopted
Biophytis announces the approval of all the resolutions presented by the Company and falling within the remit of the Ordinary and Extraordinary General Meeting.
Thanks to the mobilization of shareholders, the Meeting could be held with a quorum of almost 34% of the shareholders present or represented.
The resolutions notably included the approval of the financial statements fo the fiscal year 2023 and the renewal for three years of Stanislas Veillet, Nadine Coulm and Claude Allary as Directors. The results of the votes are available on the Biophytis website in the “Investors / General Meetings” section.